Scholarlink

Background <p>Perfluorooctane sulfonic acid (PFOS) is a legacy chemical, that while banned in some countries, is still found in various environmental media and in nearly all humans given its long half-life.</p> Objective <p>We examined mean birth weight (BW) differences in relation to PFOS exposure biomarkers using systematic review methods.</p> Methods <p>We fit a random effects model to obtain the overall pooled effect and for stratified analyses examining biomarker sample type and timing, study confidence, scaling factors, and country of study origin. We also conducted a meta-regression to assess the impact of gestational age and other factors on the overall pooled effect.</p> Results <p>We found a 30-gram BW deficit (β = −30.3 g; 95%CI: −41.6, −18.9) with each ln-unit PFOS increase based on 53 studies identified in the systematic literature review. We detected BW deficits across all study confidence levels (β range: −27 to −37 g per ln-unit increase) with the largest deficit in the <i>medium</i> confidence grouping (β = −36.6 g; 95%CI: −56.3, −16.8). We did not see evidence of a gradient of BW deficits across biomarker sample timing (β range: −24 to −39 g per ln-unit increase), but the smallest deficit in our primary analyses was detected for the 18 early sample timing studies (β = −23.6 g; 95%CI: −38.7, −8.6). Robust deficits were also seen across various subgroups including by geographical region of study origin (e.g., Asian studies), more restrictive early biomarker sample collection, and post-partum samples (β range: −16.9 to −30.6 g). For meta-regression analyses, none of the investigated factors explained significant heterogeneity across studies.</p> Impact <p>We detected a statistically significant BW&#xa0;deficit of 30 grams per each ln-unit PFOS increase across all 53 studies in our meta-analysis; results were comparable in magnitude across study confidence, sample timing, and other strata. Unlike previous meta-analyses based on fewer studies, our results suggest that pregnancy hemodynamics do not fully explain the overall association. Characterization of the potential risk of developmental effects related to PFOS and other legacy chemicals will have important risk assessment and risk management ramifications in the future.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Birth weight in relation to maternal and neonatal biomarker concentration of perfluorooctane sulfonic acid: a meta-analysis and meta-regression from a systematic review

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月22日

查看全文
  • J. M. Wright,
  • K. M. Rappazzo,
  • H. Ru,
  • A. L. Lee,
  • M. W. Dzierlenga,
  • T. F. Bateson,
  • E. G. Radke

摘要

Background

Perfluorooctane sulfonic acid (PFOS) is a legacy chemical, that while banned in some countries, is still found in various environmental media and in nearly all humans given its long half-life.

Objective

We examined mean birth weight (BW) differences in relation to PFOS exposure biomarkers using systematic review methods.

Methods

We fit a random effects model to obtain the overall pooled effect and for stratified analyses examining biomarker sample type and timing, study confidence, scaling factors, and country of study origin. We also conducted a meta-regression to assess the impact of gestational age and other factors on the overall pooled effect.

Results

We found a 30-gram BW deficit (β = −30.3 g; 95%CI: −41.6, −18.9) with each ln-unit PFOS increase based on 53 studies identified in the systematic literature review. We detected BW deficits across all study confidence levels (β range: −27 to −37 g per ln-unit increase) with the largest deficit in the medium confidence grouping (β = −36.6 g; 95%CI: −56.3, −16.8). We did not see evidence of a gradient of BW deficits across biomarker sample timing (β range: −24 to −39 g per ln-unit increase), but the smallest deficit in our primary analyses was detected for the 18 early sample timing studies (β = −23.6 g; 95%CI: −38.7, −8.6). Robust deficits were also seen across various subgroups including by geographical region of study origin (e.g., Asian studies), more restrictive early biomarker sample collection, and post-partum samples (β range: −16.9 to −30.6 g). For meta-regression analyses, none of the investigated factors explained significant heterogeneity across studies.

Impact

We detected a statistically significant BW deficit of 30 grams per each ln-unit PFOS increase across all 53 studies in our meta-analysis; results were comparable in magnitude across study confidence, sample timing, and other strata. Unlike previous meta-analyses based on fewer studies, our results suggest that pregnancy hemodynamics do not fully explain the overall association. Characterization of the potential risk of developmental effects related to PFOS and other legacy chemicals will have important risk assessment and risk management ramifications in the future.